focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCyanconnode Regulatory News (CYAN)

Share Price Information for Cyanconnode (CYAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.05
Bid: 8.00
Ask: 8.10
Change: 0.00 (0.00%)
Spread: 0.10 (1.25%)
Open: 8.05
High: 8.05
Low: 8.05
Prev. Close: 8.05
CYAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Fund Raising

26 Jul 2011 07:00

RNS Number : 0293L
Cyan Holdings Plc
26 July 2011
 



Cyan Holdings plc

("Cyan" or "the Company")

 

Proposed Placings

Notice of General Meeting

 

Cyan Holdings Plc (AIM:CYAN.L), announces details of proposed placings of 182,384,615 ordinary shares at 0.65 pence per ordinary share ("Placings") by XCAP Securities to raise approximately £1.1 million after expenses and a General Meeting ("GM"), to be held at 11.00 a.m. on 16 August 2011. It is intended that the net proceeds from the Placings will be used for general working capital requirements and to invest in accelerating the development of our lighting system as well as to invest in pursuing strategic metering engagements. XCAP Securities PLC acted as an agent to the Placings. A document containing the notice of the GM has been posted to all shareholders in the Company and is available to view on the Company's website at: www.cyantechnology.com.

Background to and reasons for the Placings

As recent announcements demonstrate, Cyan is experiencing a rapid growth in the number and frequency of orders for its lighting products. Various new customers have placed an initial order for an initial project. These initial projects have total requirements significantly larger than the initial orders placed and in some cases Cyan have been able to determine the entire size of the initial projects. The Board expects each of these customers to deploy Cyan lighting control into follow-on projects, which means that the revenue potential solely from the customer contracts that the Company has already announced is significant.

The pace of new enquiries and the number of active prospects is also increasing and as Cyan expands into new geographies these increase the requirement for both working capital and local support. The Board is excited by the pace of growth of Cyan's lighting business, and wishes to accelerate the development of new back office management systems to address customer demand for secure systems capable of managing networks of hundreds of thousands of lights.

In addition, the Company is now engaged in a small number of substantial and strategically important engagements which, if realised, would lead to large orders and deployments of Cyan metering products. Additional development investment is required to maximise the Company's prospects of success with these engagements, and strength of balance sheet is expected to be a factor in the selection of a supplier.

The purpose of the Placings is to provide the Company with incremental resources for working capital and to invest in accelerating the development of our lighting system as well as to invest in pursuing the strategic metering engagements. The Company has already seen initial orders and the Board is now expecting follow-on orders to generate meaningful revenue in 2011. The Directors are excited by the activities and wish to invest to support the initial lighting customers and the large networks that they wish to control while ensuring that the resources are available to address the strategic metering engagements.

Details of the Placings

The Company intends to raise approximately £1.1 million, net of expenses, through the issue of 182,384,615 new ordinary shares (the "Placing Shares") at 0.65 pence per ordinary share (the "Placing Price") pursuant to the Placings, comprising of a VCT and a general Placing.

The Placing Price represents a discount of approximately 22.6 per cent. to the closing mid-market price of 0.84 pence per ordinary share as at 25 July 2011, the latest practicable date prior to the announcement of the Placings. The Placing Shares will, when issued, rank pari passu in all respects with the Existing Ordinary Shares, including the right to receive dividends and other distributions declared following Admission.

The Placing Shares will represent approximately 15.33 per cent. of the Company's enlarged share capital.

The Placings are being made on a non pre-emptive basis as the time delay and costs associated with a pre-emptive offer are considered by the Directors to be excessive.

Application will be made by the Company for the Placing Shares to be admitted to trading on AIM. Subject to completion of the Placings, it is expected that the Placing Shares will be admitted to trading on AIM and that dealings will commence at 8.00 a.m. on 17 August 2011 in respect of the Placing Shares.

The issue of the Placing Shares, is conditional, inter alia, upon:

(a) the approval of the Resolutions at the GM;

(b) the Placing Agreement becoming unconditional in all respects and not having been terminated in accordance with its terms; and

(c) Admission,

in each case by no later than 8.00 a.m. on 17 August 2011 (or such time and date as the Company and XCAP Securities plc may agree, being not later than 24 August 2011).

 

Pursuant to the terms of the Placing Agreement, XCAP Securities plc has conditionally agreed to use its reasonable endeavours, as agent to the Company, to place the Placing Shares at the Placing Price with certain institutional and other investors. The above obligations are subject to certain conditions including those listed above. The Placings are not underwritten.

 

The Placing Agreement contains customary warranties given by the Company with respect to its business and certain matters connected with the Placings. In addition, the Company has given certain indemnities to XCAP Securities plc in connection with the Placings and XCAP Securities plc's performance of services in relation to the Placings. XCAP Securities plc is entitled to terminate the Placing Agreement in specified circumstances.

Directors' Shareholdings

The beneficial and non-beneficial interests of the Directors in Ordinary Shares (not including Ordinary Shares held by the Cyan Employee Benefit Trust) on the date of this document and following the Placings are set out below:

 

Existing

Following the Placings

Number of Ordinary

Existing Ordinary

Number of Ordinary

Issued Ordinary

Director

Shares

Share Capital

Shares

Share Capital

Kenneth Lamb

12,178,708

1.21%

12,178,708

1.02%

Dr. John Read

10,221,470

1.01%

10,221,470

0.86%

Simon Smith

9,986,422

0.98%

9,986,422

0.83%

 

 

 

 

 

 

 

 

 

The following ordinary shares held by the Cyan Employee Benefit Trust are beneficially owned by the following Directors to the extent the share price of the Company exceeds 2.5p per ordinary share:

Number of Ordinary

Director Shares

Kenneth Lamb 30,000,000

Dr. John Read 1,000,000

Save as stated above, the Directors have no interest in the share capital of the Company.

26 July 2011

Enquiries:

Cyan Holdings plc www.cyantechnology.com

Kenn Lamb, CEO Tel: +44 (0)1954 234 400

Cenkos Securities plc

Stephen Keys / Adrian Hargrave Tel: +44 (0)20 7397 8900

XCAP Securities plc

Jon Belliss / Parimal Kumar Tel +44 (0)20 7101 7070

Media - Hansard Communications

Adam Reynolds / Nicholas Nelson / Guy McGougall Tel: +44(0)20 7245 1100

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEANXSASPFEFF
Date   Source Headline
21st May 20247:00 amRNSInvestor Presentation via Investor Meet Company
18th Apr 20247:00 amRNSAppointment of Joint Broker
17th Apr 20241:56 pmRNSHolding(s) in Company
16th Apr 20247:00 amRNSTrading Update
15th Apr 20247:00 amRNSOrder For A New Deployment In India
12th Apr 20247:00 amRNSMiddle East Energy Leadership Summit 2024
15th Jan 20247:00 amRNSAppointment of Non-Executive Director
11th Jan 20247:00 amRNSOrder For One Million Omnimesh Modules
27th Dec 20234:18 pmRNSDirector Dealing
19th Dec 20237:00 amRNSInterim Results
6th Dec 20231:32 pmRNSChange of Registered Office
1st Dec 20234:18 pmRNSHolding(s) in Company
21st Nov 20232:31 pmRNSHolding(s) in Company
20th Nov 20236:14 pmRNSIssue of Share Options – Correction
20th Nov 20237:00 amRNSNamed as One of the Fastest Growing Companies
17th Nov 20233:45 pmRNSDirector Option Grants
17th Nov 20238:30 amRNSHolding(s) in Company
16th Nov 202312:48 pmRNSHolding(s) in Company
15th Nov 20237:00 amRNSRanked 2nd Fastest-Growing UK Company in India
13th Nov 20236:11 pmRNSPlacing and Subscription – update
9th Nov 20238:02 amRNSResult of Oversubscribed Placing and Subscription
8th Nov 20235:24 pmRNSProposed Placing and Subscription to Raise c.£2.5m
31st Oct 20237:15 amRNSContract in the Middle East and North Africa
10th Oct 20237:00 amRNSOrder for 300,000 Omnimesh Modules
5th Oct 20237:00 amRNSTrading Update
24th Aug 202312:18 pmRNSResult of AGM
17th Aug 20231:00 pmRNSHolding(s) in Company
15th Aug 20237:00 amRNS2023 Annual General Meeting
4th Aug 20235:34 pmRNSDirector Dealing
2nd Aug 20237:00 amRNSOrder for 300,000 Omnimesh Modules
26th Jul 20235:34 pmRNSCorrection: Final Results
26th Jul 20237:00 amRNSFinal Results
25th Jul 20237:00 amRNSNotice of Results & Investor Presentation
6th Jul 20237:00 amRNSTrading Update
22nd Jun 20237:00 amRNSCyanConnode India is a Start-Up 50 Trailblazer
25th May 20238:10 amRNSOrder for 600,000 Omnimesh Modules
9th May 20233:45 pmRNSHolding(s) in Company
17th Apr 20237:00 amRNSInterview with MD & CEO for CyanConnode India
3rd Apr 20237:00 amRNSCyanConnode and Alfanar Sign MOU for AMI projects
21st Mar 20237:15 amRNSHardman Research - Acceleration and revenue uplift
13th Mar 20237:00 amRNSCyanConnode Banking Arrangements
7th Mar 20237:00 amRNSCollaboration with Silicon Laboratories
6th Mar 20237:00 amRNSAppointment of Nominated and Financial Adviser
6th Feb 20238:51 amRNSStrategic Framework Agreement - Replacement
6th Feb 20238:21 amRNSStrategic Framework Agreement
6th Feb 20237:00 amRNSStrategic Framework Agreement
31st Jan 20237:00 amRNSHolding(s) in Company
24th Jan 20238:00 amRNSResult of Oversubscribed Placing and Subscription
23rd Jan 20235:11 pmRNSProposed Placing and Subscription
19th Jan 20237:00 amRNSChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.